Related Experiment Video
Updated: Sep 25, 2025

07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
572
Precision Probiotic Medicine to Improve ICB Immunotherapy
Blanda Di Luccia, Marco Colonna1
1Department of Pathology and Immunology, Washington University in St. Louis-School of Medicine, St. Louis, Missouri.
Cancer Discovery
|May 2, 2022
Summary
Probiotic exopolysaccharide EPS-R1 expands gut T cells, enhancing response to cancer immunotherapy (ICB). This finding offers new avenues for microbial-based cancer treatments.
Area of Science:
- Immunology
- Microbiology
- Cancer Research
Background:
- Gut microbiota and probiotics influence cancer immunotherapy.
- Identifying microbial metabolites to enhance tumor immune therapy is crucial.
Discussion:
- Exopolysaccharide EPS-R1 from Lactobacillus delbrueckii subsp. bulgaricus augments ICB therapy response.
- EPS-R1 expands Peyer's patches CCR6+ CD8+ T cells.
- These T cells migrate to tumors, enhancing antitumor activity.
Key Insights:
- Microbial exopolysaccharides can modulate the immune system for therapeutic benefit.
- Targeting gut T cell populations may improve cancer treatment efficacy.
- Lactobacillus-derived compounds show promise in immuno-oncology.
Outlook:
- Further research into EPS-R1 and similar molecules for cancer therapy development.
- Exploring the mechanisms of T cell migration and tumor infiltration.
- Investigating the broader applications of probiotic metabolites in cancer treatment.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
687
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
687
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
282
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
282
Microorganisms in Medicine and Therapeutics
417
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
417

